rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Joshua H. Bilenker

Director

Company insider

Files Form 4 as: Director, Sana Biotechnology; Director, Gossamer Bio; President & CEO, Loxo Oncology; Director and 10% owner, ViewRay; Director, T2 Biosystems.

Every Form 4 they filed

In numbers

Trades disclosed
282
Buys
1
Sells
35
Bought
$500K
Sold
$43.2M
Companies
5
Companies where not an officer
4
First trade
3 Oct 2001
Last trade
4 Jun 2026
Last filed
5 Jun 2026

Companies traded

Where they are an officer
Loxo OncologyDirector, Officer · last 15 Feb 20190 buys · 35 sells
Everywhere else they filed: board seats, 10% stakes, other companies
SANA Sana BiotechnologyDirector · Biotechnology · last 4 Jun 20261 buy · 0 sells
GOSS Gossamer BioDirector · Biotechnology · last 9 Jun 20220 buys · 0 sells
ViewRayDirector, 10% owner · last 13 Sep 20160 buys · 0 sells
T2 BiosystemsDirector · last 17 Jun 20160 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 Jun 2026filed 5 Jun 2026SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—90,000 at $0.00filing
4 Jun 2026filed 5 Jun 2026SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—90,000 at $0.00filing
5 Jun 2025filed 9 Jun 2025SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
6 Jun 2024filed 15 Jul 2024SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—65,000 at $0.00filing
6 Jun 2024filed 7 Jun 2024SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—54,278 at $0.00filing
8 Jun 2023filed 9 Jun 2023SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—65,000 at $0.00filing
9 Jun 2022filed 15 Jul 2022GOSS Gossamer Biooption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
6 Jun 2022filed 8 Jun 2022SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—65,000 at $0.00filing
9 Jun 2021filed 10 Jun 2021GOSS Gossamer Biooption or derivative · BiotechnologySEC FORM 4 Code A—23,500 at $0.00filing
3 Feb 2021filed 17 Feb 2023SANA Sana BiotechnologyBiotechnologySEC FORM 4 Bought$500K20,000 at $25.00filing
3 Feb 2021filed 18 Feb 2021SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—11,795 at $0.00filing
3 Feb 2021filed 5 Feb 2021SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—7,000 at $0.00filing
17 Jun 2020filed 18 Jun 2020GOSS Gossamer Biooption or derivative · BiotechnologySEC FORM 4 Code A—23,500 at $0.00filing
10 Jun 2019filed 11 Jun 2019GOSS Gossamer Biooption or derivative · BiotechnologySEC FORM 4 Code A—23,500 at $0.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$6.5M27,459 at $235.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$15.2M64,471 at $235.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$74.9M318,514 at $235.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$33.4M142,000 at $235.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$49.1M209,000 at $235.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$23.5M100,000 at $235.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed35

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.